CD Genomics is a pioneering brand in genomics research, offering high-quality next-generation sequencing, PacBio SMRT sequencing, Oxford Nanopore sequencing, and microarray services. With advanced technology platforms for NGS, long-read sequencing, and microarray instruments, CD Genomics is equipped to meet the increasing demand for these services. Their team of senior bioinformaticians have extensive experience working with various sequencing platforms, ensuring reliable results for pharmaceutical and biotechnology companies, as well as academia and government agencies.

CD Genomics provides comprehensive solutions tailored to specific research needs, offering quality sequencing and bioinformatics services. Rigorous quality checks and multiple quality control steps are implemented to ensure compliance and deliver the best products. Their long-read sequencing solutions from PacBio and ONT enable researchers to access cutting-edge sequencing services for a wide range of projects.

In addition, CD Genomics offers genotyping services, with robust and reproducible PCR assays developed by highly-trained scientists. Microarray services are also available, covering extraction to data analysis for various sample types. With a dedicated bioinformatics analysis team and high-performance computing platform, CD Genomics delivers services in genomics, transcriptomics, microorganisms, epigenetics, and single-cell omics.

Customers from over 50 countries and regions trust CD Genomics for their genomics research needs. Testimonials highlight the company's thorough responses, competitive prices, high-quality customer service, and prompt technical support. CD Genomics has established long-standing partnerships with leading institutions around the world, exemplifying their trusted reputation in the industry.

Reach out to CD Genomics for their comprehensive services in next-generation sequencing, long-read sequencing, genotyping, bioinformatics, and microarray